1Jeju Center for Infectious Diseases Control and Prevention, Jeju, Korea
2Department of Preventive Medicine, Jeju National University College of Medicine, Jeju, Korea
Copyright © 2021 The Korean Society for Preventive Medicine
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICT OF INTEREST
The authors have no conflicts of interest associated with the material presented in this paper.
FUNDING
None.
AUTHOR CONTRIBUTIONS
Conceptualization: MH, JMB. Data curation: MH. Formal analysis: MH, JMB. Funding acquisition: None. Methodology: JMB. Project administration: JMB. Visualization: MH. Writing – original draft: MH. Writing – review & editing: MH, JMB.
Values are presented as number (%).
Group A: confirmed patients who traveled overseas or came into contact with individuals who had traveled overseas; Group B: confirmed patients who had visited other provinces in Korea or came into contact with those who did; Group C: confirmed patients with no identifiable source of infection in Jeju Province.
Characteristics | Group A (n = 38) | Group B (n = 199) | Group C (n = 390) | Total (n=627) | p-value1 |
---|---|---|---|---|---|
Sex | |||||
Male | 18 (47.4) | 93 (46.7) | 189 (48.5) | 300 (47.8) | 0.920 |
Female | 20 (52.6) | 106 (53.3) | 201 (51.5) | 327 (52.2) | |
Age (y) | |||||
0-19 | 1 (2.6) | 21 (10.6) | 72 (18.5) | 94 (15.0) | <0.001 |
20-39 | 26 (68.4) | 69 (34.7) | 80 (20.5) | 175 (27.9) | |
40-59 | 8 (21.1) | 80 (40.2) | 145 (37.2) | 233 (37.2) | |
≥60 | 3 (7.9) | 29 (14.6) | 93 (23.8) | 125 (19.9) | |
Clinical | |||||
Symptomatic | 8 (21.1) | 136 (68.3) | 251 (64.4) | 395 (63.0) | <0.001 |
Asymptomatic | 30 (78.9) | 63 (31.7) | 139 (35.6) | 232 (37.0) |
Values are presented as number (%).
Group A: confirmed patients who traveled overseas or came into contact with individuals who had traveled overseas; Group B: confirmed patients who had visited other provinces in Korea or came into contact with those who did; Group C: confirmed patients with no identifiable source of infection in Jeju Province.
1 Chi-square test.
Group | Source of infection | n (%) | ||
---|---|---|---|---|
Total | 627 (100) | |||
Group A (n = 38) | ||||
Source from overseas | a. Imported cases | 37 (5.9) | ||
b. Linked to imported cases (a) | 1 (0.2) | |||
Group B (n = 199) | ||||
Source from outside Jeju province | c. Visit/contact cases in other cities/provinces | 97 (15.5) | ||
d. Major clusters of visit/contact cases in other cities/provinces (c) | 52 (8.3) | |||
Seogwipo-si, S sauna | 7 | |||
Jeju-si, Development Center | 5 | |||
Jeju-si, guest house | 5 | |||
Gyeongnam Jinju-si, group training | 14 | |||
Jeju-si, mission group | 12 | |||
Jeju-si, occupational rehabilitation center | 9 | |||
e. Linked to visit/contact cases in other cities/provinces (c) | 50 (8.0) | |||
Group C (n = 390) | ||||
Unknown source of infection | f. Major clusters in Jeju | 244 (38.9) | ||
Jeju-si, high school | 13 | |||
Jeju-si East, religious facility | 33 | |||
Jeju-si, academy | 8 | |||
Jeju-si, H sauna | 86 | |||
Jeju-si, live café | 61 | |||
Jeju-si, welfare facility for disabled | 21 | |||
Jeju-si, welfare facility for children | 15 | |||
Jeju-si, restaurant | 7 | |||
g. Under investigation | 47 (7.5) | |||
h. Linked to under investigation (g) | 99 (15.8) |
Month | Group A (n = 38) | Group B (n = 199) | Group C (n = 390) | Total (n = 627) |
---|---|---|---|---|
Feb 20 | 0 (0.0) | 2 (1.0) | 0 (0.0) | 2 (0.3) |
Mar 20 | 5 (13.2) | 2 (1.0) | 0 (0.0) | 7 (1.1) |
Apr 20 | 4 (10.5) | 0 (0.0) | 0 (0.0) | 4 (0.6) |
May 20 | 1 (2.6) | 1 (0.5) | 0 (0.0) | 2 (0.3) |
Jun 20 | 4 (10.5) | 0 (0.0) | 0 (0.0) | 4 (0.6) |
Jul 20 | 2 (5.3) | 5 (2.5) | 0 (0.0) | 7 (1.1) |
Aug 20 | 1 (2.6) | 19 (9.5) | 0 (0.0) | 20 (3.2) |
Sep 20 | 4 (10.5) | 9 (4.5) | 0 (0.0) | 13 (2.1) |
Oct 20 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Nov 20 | 4 (10.5) | 18 (9.0) | 0 (0.0) | 22 (3.5) |
Dec 20 | 4 (10.5) | 73 (36.7) | 263 (67.4) | 340 (54.2) |
Jan 21 | 4 (10.5) | 21 (10.6) | 76 (19.5) | 101 (16.1) |
Feb 21 | 2 (5.3) | 24 (12.1) | 22 (5.6) | 48 (7.7) |
Mar 21 | 3 (7.9) | 25 (12.6) | 29 (7.4) | 57 (9.1) |
Characteristics | Group A (n = 38) | Group B (n = 199) | Group C (n = 390) | Total (n=627) | p-value |
---|---|---|---|---|---|
Sex | |||||
Male | 18 (47.4) | 93 (46.7) | 189 (48.5) | 300 (47.8) | 0.920 |
Female | 20 (52.6) | 106 (53.3) | 201 (51.5) | 327 (52.2) | |
Age (y) | |||||
0-19 | 1 (2.6) | 21 (10.6) | 72 (18.5) | 94 (15.0) | <0.001 |
20-39 | 26 (68.4) | 69 (34.7) | 80 (20.5) | 175 (27.9) | |
40-59 | 8 (21.1) | 80 (40.2) | 145 (37.2) | 233 (37.2) | |
≥60 | 3 (7.9) | 29 (14.6) | 93 (23.8) | 125 (19.9) | |
Clinical | |||||
Symptomatic | 8 (21.1) | 136 (68.3) | 251 (64.4) | 395 (63.0) | <0.001 |
Asymptomatic | 30 (78.9) | 63 (31.7) | 139 (35.6) | 232 (37.0) |
Values are presented as number (%). Group A: confirmed patients who traveled overseas or came into contact with individuals who had traveled overseas; Group B: confirmed patients who had visited other provinces in Korea or came into contact with those who did; Group C: confirmed patients with no identifiable source of infection in Jeju Province.
Values are presented as number (%). Group A: confirmed patients who traveled overseas or came into contact with individuals who had traveled overseas; Group B: confirmed patients who had visited other provinces in Korea or came into contact with those who did; Group C: confirmed patients with no identifiable source of infection in Jeju Province. Chi-square test.